ERKENTNIS: Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Cancer, Pain
Both
Cancer, Pain
Trial Information
ERKENTNIS: Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability
In addition to the effectiveness of Effentora® therapy, safety, general feasibility and the
impact of therapy on the patients' quality of life are of interest.
Inclusion Criteria:
- decision to start treatment with Effentora
- prescription in accordance with Summary of Product Characteristics (SmPC)
- personally signed and dated Informed Consent document
Exclusion Criteria:
- any subject considered unsuitable according to SmPC
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
pain relief
Outcome Description:
to show adequate pain relief within 10 minutes
Outcome Time Frame:
4 weeks
Safety Issue:
No
Principal Investigator
Medical Department
Investigator Role:
Study Director
Investigator Affiliation:
Cephalon
Authority:
Germany: Federal Institute for Drugs and Medical Devices
Study ID:
C25608/5008
NCT ID:
NCT01400854
Start Date:
July 2011
Completion Date:
October 2012
Related Keywords:
- Cancer
- Pain
- breakthrough cancer pain
Name | Location |
|---|
